History

CELLnLIFE inc.

2021

Apr.

May.

Jun.

Jul.

Nov.

Selected for the disease-focused translational research project by the Ministry of Health and Welfare

Completed GMP manufacturing facility in Guro, Seoul

Approval of aGVHD phase 1 clinical trial for adults by the Ministry of Food and Drug-Safety
Awarded the 15th Korea Excellent Patent Grand Prize by Hankook Ilbo

Awarded the 3rd Korea Small and Medium Business startup Grand Prize by Korea Venture Capital Association

2020

May.

Jun.

Oct.

Nov.

Selected as an innovative growth support company in the big 3 fields by the Ministry of SMEs and Startups

Selected for the research manpower support project for technology innovative SMEs by the Ministry of SMEs and Startups

Series A investment

Selected for the SME technology innovation development project by the Ministry of SMEs and Startups
Moved the business site (Guro-gu, seoul) and operated the SEOUL BIOHUB branch

2019

Apr.

Nov.

Technology transfer contract from Samsung Seoul Hospital

Selected for the startup growth technology development project by the Ministry of SMEs and Startups
Selected for the bio/medical technology commercialization support project by Seoul Business Agency

2018

Aug.

Sep.

Dec.

Established CellnLife corporation and selected as a resident company for SEOUL BIOHUB

Accredited as a business-affiliated research institute by KOITA

Certified as a Venture company by Korea Technology Finance Corporation
Selected for the research manpower support project for technology innovative SMEs by the Ministry of SMEs and Startups

2022

Jan.

Apr.

Jun.

Jul.

Selected as the 7th IBK CHANGGONG innovative start-up company in Guro

Selected for the R&D projects by Korean Fund for Regenerative Medicine

Selected for the basic research project by the Ministry of Science and ICT

Graduated from SEOUL BIOHUB startup incubator (4 years)